Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Zenyth Operations Pty Ltd. currently has 1 pending office action. The company is interacting with 1 distinct examiner to resolve this matter. The busiest examiner, NATARAJAN, MEERA, is assigned 1 busiest examiner pending office action. There are 0 distinct art units listed for this portfolio, focusing the current prosecution on a 1 examiner relationship. This structure indicates that the company is not currently managing a broad or diverse set of patent filings.
The prosecution strategy for Zenyth Operations Pty Ltd. is centralized, as the 1 pending office action is the only outstanding item. With 1 distinct examiner involved, there is no need to balance different examiner preferences or art unit standards. The practitioner should prioritize the specific requirements of NATARAJAN, MEERA to advance the 1 busiest examiner pending office action. This focused approach allows for a clear and direct path toward resolving the company's current intellectual property matters within the 0 distinct art units provided.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NATARAJAN, MEERA | 1 | 62.5% | +18.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18499051 | ANTIBODY MOLECULE FOR HUMAN GM-CSF RECEPTOR ALPHA | NATARAJAN, MEERA | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18499051 | ANTIBODY MOLECULE FOR HUMAN GM-CSF RECEPTOR ALPHA | NATARAJAN, MEERA | — | §112 | Non-Final OA | — | Pending | Oct 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial